CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Update: Alector Shares Rise After Licensing AL050 Program to Roche's Genentech

PartnershipAL050Positive
AI Analysis

Summary

Alector has licensed its AL050 program to Roche's Genentech subsidiary, resulting in a rise in Alector's share price.

Importance:7/10
Sentiment:
0.70
licensingpartnershipstock_movement
Related Companies

Read the original article

Published by yahoo_finance on October 5, 2026 7:04 PM

Read Original